Age and gender characteristics of dyslipidemia prevalence among the Bishkek city residents

Materials and methods. The results of lipid profile cross-sectional study of 2088 Bishkek residents aged 18—65 years who came to “Bonetsky Laboratory” from January to December 2016 were analyzed.

Results. Among 2088examined residents there were 938 (44.9 %) men and 1150 (55.1 %) women; 48.4 % of them had an increased level of total cholesterol (≥5.2 mmol / l). The prevalence of hypercholesterolemia (HC) in women was higher (52.3 %) than in men (43.6 %). With age in both men and women, the increased frequency of HC was found, in men the peak was observed at the age of50—59years (50.3 %), and in women >60 years (61.2 %). HC associated with lipoprotein content (low-density lipoprotein >2.58 mmol/l) was found in 80.0 %, and in women more often than in men (81.6 and 78.1 % respectively). In both male and female, the greatest rise in HC dynamics was observed at the age of30—39years, then a monotonous rise of HCfrequency was observed in women (86.0 %) >60years, and in men the subsequent rise of HC from the age of 30—39 years was not observed. Reduced levels of high density lipoproteins up to 30 years of age were more common in women than in men (46.4 % vs 29.0 %). The peak in the frequency of low level of high density lipoproteins was found at the age of40—49years and was more often in women. Hypertriglyceridemia (>1.7 mmol/l) up to 30 years of age was registered with the same frequency regardless of gender and age (36.0 % in women, 37.0 % in men). Two-factor variance analysis for the lipid profile showed a high statistical significance of gender and age.

Conclusion. The study showed a high prevalence of dyslipidemia among the population of Bishkek city. The presented data justify the necessity of active prophylaxis for primary and secondary prevention of ischemic heart disease among the population.

1. Catapano A. L., Graham I., De Backer G. et al. 2016 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J 2016;37(39):2999—3058. DOI: 10.1093/eurheartj/ehw272.

2. Kotseva K., Wood D., De Bacquer D. et al. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016;23 (6):636—48. DOI: 10.1177/2047487315569401.

3. S. A., Deev A. D. Characteristics of high risk patients. Results of the epidemiological part of the scientific and educational program OSCAR. Kardiovaskulyarnaya terapiya i profilak-tika = Cardiovascular Therapy and Prevention 2006;5(5):58—63. (In Russ.).

4. Akhmedzhanov N. M., Nebieridze D. V., Safaryan A. S. et al. Analysis of hypercholesterolemia prevalence in the outpatient practice (according to the ARGO study). Racional’naya farmakoterapiya v kardiologii = Rational Pharmacotherapy in Cardiology 2015;11(3):253—60. (In Russ.). DOI: 10.20996/1819-6446-2015-11-3-253-260.

5. The health of the population and activities of healthcare organizations of the Kyrgyz Republic in 2017. RMIC: Bishkek, 2018. (In Russ.).

6. Aitbaev K. A., Murataliev T. M. Atherogenic dyslipidemia among the population of the Kyrgyz Republic: prevalence, association with coronary heart disease, susceptibility to lipid-correcting therapy. Central’no-aziatskij medicinskij zhurnal = Central Asian Medical Journal 2007;13(1):40—5. (In Russ.).

7. Aitbaev K. A., Trufanov V. F., Meimanaliev T. S., Igemberdieva R. A. Blood serum lipids of men, indigenous villagers of the foothills of Kyrgyzstan. Voprosy medicinskoj himii = Questions of Medical Chemistry 1985;31(6):112—4. (In Russ.).

8. Polupanov A. G., Khalmatov A. N., Altymysheva A. T. et al. The prevalence of dyslipidemia among the residents of the Kyrgyz Republic of working age (according to the international study “Interepid”). Vestnik KRSU = Vestnik of the KRSU 2014;14(5):128—32. (In Russ.).

9. Martin M. J., Hulley S. B., Browner W. S. et al. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet 1986;2(8516):933—6. PMID: 2877128.

10. Willett W. C. The WHI joins MRFIT: a revealing look beneath the covers. Am J Clin Nutr 2010;91(4):829—30. DOI: 10.3945/ajcn.2010.29347.

11. uromtseva G. A., Kontsevaya A. V., Konstantinov V. V. et al. The prevalence of risk factors for noncommunicable diseases in the Russian population in 2012—2013. The results of ESSE-RF study. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention 2014;13(6):4—11. (In Russ.).

12. Expert Dyslipidemia Panel, S. M. Grundy. Expert Dislipidemia Panel, An International Atherosclerosis Society Position Paper: global recommendations for the management of dislipidemia. J Clin Lipidol 2013;7(6):561—5. DOI: 10.1016/j.jacl.2013.10.001

13. Urazgildieva S. A., Nizhegorodtsev M. Yu., Sadovnikov P. S. et al. Age and gender characteristics of the lipid blood spectrum of urban residents (according to the results of cross-cultural research). Racional’naya farmakoterapiya v kardio-logii = Rational Pharmacotherapy in Cardiology 2017;13(5):637—44. (In Russ.). DOI: 10/20996/1819-6446-2017-13-5-637-644.

14. Abbott R. D., Wilson P. W., Kannel W. B., Castelli W. P. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study. Arteriosclerosis 1988;8(3):207—11. PMID: 3370018.

15. Stamler J., Neaton J. D., Cohen J. D. et al. Multiple risk factor intervention trial revisited: a new perspective based on nonfatal and fatal composite endpoints, coronary and cardiovascular, during the trial. J Am Heart Assoc 2012;1(5):e003640. DOI: 10.1161/jaha.112.003640.

16. Boytsov S.A., Lukyanov M. M., Yakushin S. S. et al. The register of cardiovascular diseases (REKVAZA): diagnostics, combined cardiovascular pathology, comorbidities and treatment in the conditions of real out-patient polyclinic practice. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention 2014;13(6):44—50. (In Russ.).

17. Sarwar N., Danesh J., Eiriksdottir G. et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 western prospective studies. Circulation 2007;115(4):450—8. DOI: 10.1161/circulationaha.106.637793.